Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-11

Clinical Trial Update: Qutenza for Critical Ischaemia in End Stage Renal Failure [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating Qutenza (capsaicin patch) for critical limb ischemia in patients with end-stage renal disease, including considerations …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUTENZA (Capsaicin)

Snippet

Sponsor: Emma Aitken | Conditions: End Stage Renal Failure, Neuropathic Pain | Phase 4 | Status: UNKNOWN